JP2005526113A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526113A5
JP2005526113A5 JP2003587802A JP2003587802A JP2005526113A5 JP 2005526113 A5 JP2005526113 A5 JP 2005526113A5 JP 2003587802 A JP2003587802 A JP 2003587802A JP 2003587802 A JP2003587802 A JP 2003587802A JP 2005526113 A5 JP2005526113 A5 JP 2005526113A5
Authority
JP
Japan
Prior art keywords
general formula
hal
sons
edition
march
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003587802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526113A (ja
Filing date
Publication date
Priority claimed from HU0201374A external-priority patent/HU227255B1/hu
Application filed filed Critical
Publication of JP2005526113A publication Critical patent/JP2005526113A/ja
Publication of JP2005526113A5 publication Critical patent/JP2005526113A5/ja
Withdrawn legal-status Critical Current

Links

JP2003587802A 2002-04-26 2002-12-28 新規なピペリジニル−アルキルアミノ−ピリダジノン誘導体、その製法及びこの化合物を含有する医薬組成物 Withdrawn JP2005526113A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0201374A HU227255B1 (en) 2002-04-26 2002-04-26 Novel piperidine-alkyl-amino-pyridazine derivatives, pharmaceutical compositions containing the same and process for the preparation of the active ingredient
PCT/HU2002/000171 WO2003091244A1 (en) 2002-04-26 2002-12-28 New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds

Publications (2)

Publication Number Publication Date
JP2005526113A JP2005526113A (ja) 2005-09-02
JP2005526113A5 true JP2005526113A5 (enExample) 2006-01-05

Family

ID=89980388

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003587802A Withdrawn JP2005526113A (ja) 2002-04-26 2002-12-28 新規なピペリジニル−アルキルアミノ−ピリダジノン誘導体、その製法及びこの化合物を含有する医薬組成物

Country Status (24)

Country Link
US (1) US7183283B2 (enExample)
EP (1) EP1501823B1 (enExample)
JP (1) JP2005526113A (enExample)
KR (1) KR20040104608A (enExample)
CN (1) CN1289495C (enExample)
AT (1) ATE312091T1 (enExample)
AU (1) AU2002356351A1 (enExample)
BR (1) BR0215672A (enExample)
CA (1) CA2480293A1 (enExample)
CY (1) CY1105422T1 (enExample)
CZ (1) CZ20041085A3 (enExample)
DE (1) DE60207895T2 (enExample)
DK (1) DK1501823T3 (enExample)
EA (1) EA007202B1 (enExample)
ES (1) ES2254793T3 (enExample)
HU (1) HU227255B1 (enExample)
MX (1) MXPA04010411A (enExample)
NO (1) NO20045124L (enExample)
NZ (1) NZ536639A (enExample)
PL (1) PL371520A1 (enExample)
SI (1) SI1501823T1 (enExample)
SK (1) SK50162004A3 (enExample)
WO (1) WO2003091244A1 (enExample)
ZA (1) ZA200408849B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004010207A1 (de) * 2004-03-02 2005-09-15 Aventis Pharma S.A. Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
HUP0600555A3 (en) * 2006-07-03 2008-10-28 Egis Gyogyszergyar Nyrt Use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]izoxazol-3-yl)piperidin-1-yl]ethylamino}2-methyl-3(2h)-piridazinon for the production of pharmaceutical compositions for influencing cognitive functions and causing neuroprotective effect
US20100211495A1 (en) * 2009-02-13 2010-08-19 Bank Of America Corporation Systems, methods and computer program products for improving foreign currency exchange in a comprehensive payment hub system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225955B1 (en) * 2001-07-26 2008-01-28 Egis Gyogyszergyar Nyilvanosan Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them

Similar Documents

Publication Publication Date Title
TW200726754A (en) Chemical process
JP2004536811A5 (enExample)
CA2360303A1 (en) Process for the preparation of pure citalopram
JP2006188470A (ja) インドリン誘導体およびその製造方法
CA2447803A1 (en) Synthesis of 4-phenylbutyric acid
JP2004532624A5 (enExample)
JP2005526113A5 (enExample)
TW200420744A (en) Ruthenium compound and process for producing metallic ruthenium film
JP2006526890A5 (enExample)
MXPA05008842A (es) Proceso quimico.
US6689913B2 (en) Process for preparing terbinafine and HCI salt thereof
RU2007123668A (ru) Способ получения дихлорангидрида фталевой кислоты
Zhi et al. New catalytic system for aminohalogenation of β-methyl-β-nitrostyrenes to give opposite regiochemistry
TW201302672A (zh) 不飽和羧酸醯胺組成物之製造方法
JP4712320B2 (ja) 2−オキソ−1−フェニル−3−オキサビシクロ[3.1.0]ヘキサンの製造方法
CN106631686A (zh) 一种β‑苯乙醇的制备方法
PL1817274T3 (pl) Sposób wytwarzania amino- albo hydroksybenzonitryli
JPWO2016133217A1 (ja) 光学活性オキシインドール化合物の製造方法及びそれに触媒として用いられるトリアゾリウム塩
CN106431983B (zh) 一种2-苄氧基苯甲腈类化合物及其制备方法
WO2005080329A3 (en) Process for manufacture of racemic carvedilol
Junfeng et al. Efficient Oxidative Coupling of Isochroman with Primary Arylamines Catalyzed by Heterogeneous Ni-Containing Layered Double Oxide
JP2005524716A5 (enExample)
JPS6216441A (ja) 1,4−ジクロロブタンの製造法
Degani et al. Preparation of N, N-dimethyl-N′-arylureas using S, S-dimethyl dithiocarbonate as a carbonylating reagent
JP4310284B2 (ja) エナミドのアゾ化合物への求核付加反応方法